BEIJING, 28 février (Xinhua) — L’Administration nationale des produits pharmaceutiques de la Chine a accordé une autorisation conditionnelle d’entrée sur le marché à un nouveau vaccin recombinant contre le nouveau coronavirus qui ne nécessite qu’une seule injection.
Le 26 février, le gouvernement a publié la Résolution N°21/NQ-CP sur l’achat et l’utilisation de vaccins anti-COVID-19.
The Vietnamese Ministry of Health has authorized the use of the Russian Sputnik V coronavirus vaccine in the country, official government information website announced on Friday.
It was reported that at the same time, the Ministry of Health has approved the use of the US vaccine Moderna in Vietnam. So far, the only vaccine approved by the Ministry of Health of Vietnam for use on the territory of the country was AstraZeneca.
MATSUE–Shimane Governor Tatsuya Maruyama traveled 600 kilometers to Tokyo to demand additional pandemic-related support measures while his prefectural government issued a warning about canceling its portion of the Olympic torch relay.
The government confirmed it will lift the COVID-19 state of emergency early for six prefectures, but the four Tokyo-area prefectures will have to wait until the March 7 deadline.
“We will lift the state of emergency for six prefectures as of Feb. 28,” Prime Minister Yoshihide Suga said at a government task force meeting on the evening of Feb. 26.
Surveys show wide interest among county’s residents in being inoculated
South Korea launched its COVID-19 inoculation campaign on Friday, with shots to be administered in some 200 nursing homes, in an effort that officials call the first step in returning the country to more normal life.
J’écris cet article de ma chambre d’hôtel, à Sydney, où je fais ma quarantaine après mon retour de Wuhan, en Chine. Je suis le représentant de l’Australie pour l’étude mondiale de l’Organisation mondiale de la santé (OMS) sur les origines du virus SARS-CoV-2.
– In the first three months of 2020, mortality rates in Wuhan were 56 per cent higher than estimates based on average in previous years
– But elsewhere they were lower than expected, which researchers said may be related to behavioural changes during lockdown
– Wuhan unit of state-owned Sinopharm, whose first vaccine was approved for general use in December, says second product has an efficacy rate of 72.5 per cent
– CanSino puts efficacy rate of its vaccine at 65 per cent, but says it is 90 per cent effective at preventing severe symptoms
– Mobile internet traffic during the Lunar New Year holiday week grew 23.4 per cent year on year, according to data from MIIT
– Food was an increasingly popular gift ordered online, according to the country’s top on-demand food delivery services Meituan and Alibaba’s Ele.me
Malgré l’absence de nouveaux cas de Covid-19 à Taiwan ces derniers jours, la situation mondiale reste préoccupante, raison pour laquelle la plupart des mesures de prévention adoptées ici pour l’hiver vont rester en place, a expliqué le 22 février le ministre de la Santé et des Affaires sociales, Chen Shih-chung [陳時中]. Il s’exprimait lors d’une conférence de presse du Quartier général de lutte épidémique (CECC), à Taipei.
China’s COVID-19 vaccines are effective against the two major variants of the novel coronavirus that have been imported, but sustained efforts are still needed to prevent other strains from entering, the Chinese Center for Disease Control and Prevention said.
Following the production of its second domestically developed COVID-19 vaccine, Thailand is all set to commence its human trials from as early as April this year.
The vaccine which was developed by Chulalongkorn University showed promising results in prior trials with mice and monkeys. The University’s Centre of Excellence in Vaccine Research and Development is utilizing new mRNA technology and its clinical testing on transgenic mice showed that the vaccine was able to prevent clinical symptoms and viremia after two shots. The university is looking to enroll 72 participants in the first phase of the human trials and subsequently increase the number to 300-600 participants in the second phase. The university has also begun research on a second-generation vaccine that will help grant additional protection to its citizens against the UK and South African variants of the COVID-19 virus.
Thailand will start vaccinating priority groups including health workers against COVID-19 by the end of this week, its prime minister said on Tuesday, a day ahead of the arrival of the country’s first coronavirus vaccines.
L’administration de l’Alimentation et du Médicament (FDA) de Taiwan a accordé le 20 février une autorisation d’utilisation d’urgence au vaccin d’AstraZeneca contre le Covid-19, alors que le pays s’apprête à en recevoir cette semaine les 200 000 premières doses.
